An Evaluation of the NJSPB SCF Project for Opioid-Involved High-Risk Parolees
NCT03812484 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77
Last updated 2021-02-02
Summary
This study entails an evaluation of the New Jersey State Parole Board Swift, Certain, and Fair (SCF) Supervision Program. The purpose of the evaluation is to test whether subjects assigned to SCF Supervision perform better than those assigned to parole-as-usual (PAU).
Conditions
- Substance Abuse
- Criminal Behavior
Interventions
- BEHAVIORAL
-
SCF Supervision
SCF Supervision entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). SCF Supervision includes regular random drug testing.
- BEHAVIORAL
-
Parole-as-Usual
Parolees are supervised under standard parole supervision practice in New Jersey
Sponsors & Collaborators
-
Botec Analysis, LLC
lead INDUSTRY
Principal Investigators
-
Clarissa Manning, MPP · Botec Analysis, LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-02-01
- Primary Completion
- 2020-12-31
- Completion
- 2021-03-31
Countries
- United States
Study Locations
More Related Trials
-
Relapse Prevention to Reduce HIV Among Women Prisoners
NCT00763958 ·Status: COMPLETED ·Phase: PHASE4
-
Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers
NCT02926482 ·Status: COMPLETED ·Phase: NA
-
Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees
NCT00302575 ·Status: UNKNOWN ·Phase: NA
-
PRoducing Outcome Measures for OTP Quality Improvement
NCT07214389 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1
NCT00142935 ·Status: COMPLETED ·Phase: NA
-
Towards Testing the Effectiveness of Recovery Community Centers (RCCs)
NCT07010978 ·Status: RECRUITING ·Phase: NA
-
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
NCT03616236 ·Status: SUSPENDED ·Phase: PHASE3
-
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
NCT00367302 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery
NCT07115030 ·Status: RECRUITING ·Phase: NA
-
Stepped Care for Patients to Optimize Whole Recovery
NCT05155163 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
NCT01096550 ·Status: COMPLETED ·Phase: NA
-
CBT4CBT for Office Based Buprenorphine
NCT03580902 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessing Optimal XRB Initiation Points in Jail
NCT06051890 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluating A Drug Testing and Graduated Sanctions Program in Delaware
NCT01187121 ·Status: UNKNOWN
-
Buprenorphine for Prisoners
NCT00574067 ·Status: COMPLETED ·Phase: PHASE3
-
A Brief Negotiation Interview Chatbot to Improve Buprenorphine Engagement Among Justice-Involved Individuals
NCT04982627 ·Status: COMPLETED ·Phase: NA
-
Treatment Navigation for Opioid Use Disorder
NCT03398265 ·Status: COMPLETED ·Phase: NA
-
Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution
NCT04059016 ·Status: COMPLETED
-
Effects of Remote Motivational Enhancement & MySafeRx on Post-Detox Engagement in B/N Treatment -RCT
NCT04822168 ·Status: WITHDRAWN ·Phase: NA
-
Kentucky Women's Justice Community Overdose Innovation Network - Phase II
NCT07179614 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Decision Support for Safety of Opioid Transitions
NCT06527040 ·Status: NOT_YET_RECRUITING
-
BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3
NCT02902835 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123)
NCT01396005 ·Status: COMPLETED ·Phase: PHASE1
-
Recovery Management Checkups for Opioid Use Disorder Experiment
NCT04365920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
CoMBAT Opioid Use Disorder: A Combined Medication and Behavioral Activation Treatment for People Living With Opioid Use Disorder
NCT04240093 ·Status: COMPLETED ·Phase: NA